Imugene Limited (ASX: IMU), a clinical-stage immuno-oncology company, is pleased to announce exciting new data from its Phase ...

Staff working on the contract at Fujitsu have been informed of their transfer to the Home Office under TUPE regulations. One ...

Brex reports on quickly establishing business credit through steps like registering a business, applying for an EIN, and ...

In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach ...

Explore American Battery Technology's growth potential amid U.S. electrification efforts. Learn about catalysts, risks, and ...

Detailed price information for Virtus Lifesci Biotech Clinical Trials ETF (BBC-A) from The Globe and Mail including charting and trades.

Background The burden of cardiovascular events in Africa is projected to rise significantly in the coming decade, placing ...

CRISPR Therapeutics is revolutionizing medicine with gene editing. Learn more about CRSP's breakthroughs, stock rally, and ...

Since Beijing imposed a national security law in Hong Kong in 2020, the city has seen the closure of independent media ...

GMP manufacturing completed, paediatric waiver granted, positive outcome from FDA and EMA interactions; advancing mitazalimab toward Phase 3 readinessBiomarker data from OPTIMIZE-1 presented at ASCO, ...

SIGNIFICANT EVENTS DURING 1 APRIL - 30 JUNE 2025In April, Iconovo announced an organizational change expected to reduce annual costs by approximately 14-16 MSEK starting in the third quarter of 2025.

Objectives Cardiac amyloidosis (CA) is a rare and underdiagnosed disease associated with a high mortality rate. Although, in the last decade, there has been increasing attention in the literature to ...